Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-05-28–present
Kevin C. Gorman, Ph.D.
Board Member
Neurocrine Biosciences Inc (NBIX)Equibles does not estimate personal net worth.
Get an email with a short summary when Neurocrine Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get NBIX alertsAbout Kevin C. Gorman, Ph.D.
Kevin C. Gorman, Ph.D. is recorded as Board Member at Neurocrine Biosciences Inc (NBIX) since May 28, 2026. Neurocrine Biosciences Inc reported in an 8-K filed May 28, 2026 that Kevin C. Gorman, Ph.D. was appointed Class III Director, effective May 27, 2026. Neurocrine Biosciences Inc reported in an 8-K filed May 28, 2024 that Kevin C. Gorman, Ph.D. retired as President and Chief Executive Officer, effective October 11, 2024. Neurocrine Biosciences Inc reported in an 8-K filed May 19, 2023 that Kevin C. Gorman, Ph.D. was appointed Class III Director, effective May 17, 2023. Neurocrine Biosciences Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Neurocrine Biosciences Inc includes Kevin Gorman (CEO and Board Member), Kyle Gano, Ph.D. (CEO and Board Member), Kyle W. Gano (CEO and Board Member) and 7 others.
“The three nominees for Class III Director were elected.”
“On May 28, 2024, Neurocrine Biosciences, Inc. ("Neurocrine") announced that Kevin C. Gorman, Ph.D. will retire as Neurocrine's President and Chief Executive Officer effective as of October 11, 2024 (the "Transition Date").”
Affiliation history
-
Current
2026-05-28–present
Company network
Leadership on record at Neurocrine Biosciences Inc
- Kevin Gorman CEO, Board Member
- Kyle Gano, Ph.D. CEO, Board Member
- Kyle W. Gano CEO, Board Member
- Matthew C. Abernethy CFO
- Christine A. Poon Board Member
- Gary A. Lyons Board Member
- George J. Morrow Board Member
- Johanna Mercier Board Member
- Kevin C. Gorman Board Member
- Kyle W. Gano, Ph.D. Board Member